Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael D Edstein

Showing results (51-60 of 82) with videos related to

Pageof 9
Sort By:
Antimicrobial Agents and Chemotherapy|December 10, 2009
Randomized, double-blind study of the safety, tolerability, and efficacy of tafenoquine versus mefloquine for malaria prophylaxis in nonimmune subjectsPeter E Nasveld, Michael D Edstein, Mark Reid, et al.
The Journal of Infectious Diseases|September 21, 2004
Efficacy of monthly tafenoquine for prophylaxis of Plasmodium vivax and multidrug-resistant P. falciparum malariaDouglas S Walsh, Chirapa Eamsila, Theerayuth Sasiprapha, et al.
Chemmedchem|September 15, 2015
Synthesis and Evaluation of Novel Acyclic Nucleoside Phosphonates as Inhibitors of Plasmodium falciparum and Human 6-Oxopurine PhosphoribosyltransferasesMartin M Kaiser, Dana Hocková, Tzu-Hsuan Wang, et al.
Molecular & Cellular Proteomics : MCP|December 15, 2019
Multi-omic Characterization of the Mode of Action of a Potent New Antimalarial Compound, JPC-3210, Against <i>Plasmodium falciparum</i>Geoffrey W Birrell, Matthew P Challis, Amanda De Paoli, et al.
Antimicrobial Agents and Chemotherapy|June 17, 2009
Pharmacokinetics and ex vivo pharmacodynamic antimalarial activity of dihydroartemisinin-piperaquine in patients with uncomplicated falciparum malaria in VietnamDao Van Hoang Nguyen, Quoc Phuc Nguyen, Ngoa Dang Nguyen, et al.
Antimicrobial Agents and Chemotherapy|February 10, 2016
Lead Selection of a New Aminomethylphenol, JPC-3210, for Malaria Treatment and PreventionMarina Chavchich, Geoffrey W Birrell, Arba L Ager, et al.
Journal of Medicinal Chemistry|March 2, 2013
Acyclic nucleoside phosphonates containing a second phosphonate group are potent inhibitors of 6-oxopurine phosphoribosyltransferases and have antimalarial activityDianne T Keough, Petr Špaček, Dana Hocková, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 24, 2016
Efficacy of Artesunate-mefloquine for Chloroquine-resistant Plasmodium vivax Malaria in Malaysia: An Open-label, Randomized, Controlled TrialMatthew J Grigg, Timothy William, Jayaram Menon, et al.
Chemmedchem|October 8, 2024
Exploring the Utility of Cell-Penetrating Peptides as Vehicles for the Delivery of Distinct Antimalarial Drug CargoesCaitlin L Gare, Isabella R Palombi, Andrew M White, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|March 21, 2007
Vivax malaria: preliminary observations following a shorter course of treatment with artesunate plus primaquineNguyen Van Hoang Dao, Bui Tri Cuong, Nguyen Dang Ngoa, et al.
Pageof 9

Showing results (51-60 of 82) with videos related to

Sort By:
Pageof 9
Antimicrobial Agents and Chemotherapy|December 10, 2009
Randomized, double-blind study of the safety, tolerability, and efficacy of tafenoquine versus mefloquine for malaria prophylaxis in nonimmune subjectsPeter E Nasveld, Michael D Edstein, Mark Reid, et al.
The Journal of Infectious Diseases|September 21, 2004
Efficacy of monthly tafenoquine for prophylaxis of Plasmodium vivax and multidrug-resistant P. falciparum malariaDouglas S Walsh, Chirapa Eamsila, Theerayuth Sasiprapha, et al.
Chemmedchem|September 15, 2015
Synthesis and Evaluation of Novel Acyclic Nucleoside Phosphonates as Inhibitors of Plasmodium falciparum and Human 6-Oxopurine PhosphoribosyltransferasesMartin M Kaiser, Dana Hocková, Tzu-Hsuan Wang, et al.
Molecular & Cellular Proteomics : MCP|December 15, 2019
Multi-omic Characterization of the Mode of Action of a Potent New Antimalarial Compound, JPC-3210, Against <i>Plasmodium falciparum</i>Geoffrey W Birrell, Matthew P Challis, Amanda De Paoli, et al.
Antimicrobial Agents and Chemotherapy|June 17, 2009
Pharmacokinetics and ex vivo pharmacodynamic antimalarial activity of dihydroartemisinin-piperaquine in patients with uncomplicated falciparum malaria in VietnamDao Van Hoang Nguyen, Quoc Phuc Nguyen, Ngoa Dang Nguyen, et al.
Antimicrobial Agents and Chemotherapy|February 10, 2016
Lead Selection of a New Aminomethylphenol, JPC-3210, for Malaria Treatment and PreventionMarina Chavchich, Geoffrey W Birrell, Arba L Ager, et al.
Journal of Medicinal Chemistry|March 2, 2013
Acyclic nucleoside phosphonates containing a second phosphonate group are potent inhibitors of 6-oxopurine phosphoribosyltransferases and have antimalarial activityDianne T Keough, Petr Špaček, Dana Hocková, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 24, 2016
Efficacy of Artesunate-mefloquine for Chloroquine-resistant Plasmodium vivax Malaria in Malaysia: An Open-label, Randomized, Controlled TrialMatthew J Grigg, Timothy William, Jayaram Menon, et al.
Chemmedchem|October 8, 2024
Exploring the Utility of Cell-Penetrating Peptides as Vehicles for the Delivery of Distinct Antimalarial Drug CargoesCaitlin L Gare, Isabella R Palombi, Andrew M White, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|March 21, 2007
Vivax malaria: preliminary observations following a shorter course of treatment with artesunate plus primaquineNguyen Van Hoang Dao, Bui Tri Cuong, Nguyen Dang Ngoa, et al.
Pageof 9